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Does quality of care systematically differ among government-owned, private not-for-profit, and
for-profit hospitals? A large empirical literature provides conflicting evidence. Through quantitative
review of 46 studies since 1990, we find that several study features that can explain divergent results:
analytic methods, disease studied, and data sources. For unprofitable care, how studies handle market
competition and regional differences account for substantial variation. Policymakers should be aware
that differences in results appear to arise predominantly from differences between studies’ analytic
methods. Moreover, conventional methods of meta-analytic synthesis should be applied with great
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I. Background  
Does quality of care systematically differ among government-owned, private not-for-
profit, and for-profit hospitals? This question is of considerable policy importance in the United 
States and many other countries.  A large empirical literature on this topic provides conflicting 
evidence.  Unlike the clinical literature, systematic reviews and meta-analysis remain rare for 
such questions of health service delivery, and none to date focuses on explaining the 
heterogeneity in study results.  
The objective of this systematic review is to examine what factors explain the diversity of 
findings regarding hospital ownership and quality of care, as well as measures of benefits 
provided to a hospital’s surrounding community (including uncompensated care to the poor and 
uninsured and other unprofitable services). We employ meta-regressions to quantify 
heterogeneity explained by study-level variables hypothesized to effect results—such as each 
study’s methodology to account for confounding factors, whether the study analyzes patient- or 
hospital-level data (or both), time period of the data or regions covered.  Our review is part of a 
larger project applying meta-analytic techniques to the literature since 1990 on hospital 
ownership and performance; Shen and colleagues report the results on financial performance and 
ownership.1  
The only previous systematic review of hospital ownership and quality of which we are 
aware identified 15 studies published between 1988 and 2001 comparing mortality rates among 
private not-for-profit and for-profit hospitals.2   Our study differs from theirs in several respects: 
we focus on explaining variation, rather than suggesting “one overall answer”; we include 
studies analyzing patient outcomes other than mortality (e.g., adverse events), as well as 
measures of community benefits; we include government ownership in the review; we do not 
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exclude studies analyzing ownership conversions, but rather test the hypothesis that conversion 
studies differ systematically from others; and perhaps most importantly, we address the problem 
of applying conventional meta-analytic techniques to this literature because many studies 
analyze overlapping samples of hospitals. Our literature search identified 31 studies of patient 




Literature Search, Selection and Extraction 
Data Sources.  Our literature search employed the keywords “hospitals,” “ownership,” 
“for-profit,” “not-for-profit,” “nonprofit,” and their combinations. Databases included Medline, 
EconLit (Economics Literature), and Proquest/ABI (for dissertations), as well as hand search and 
work cited in previous qualitative reviews.3  We included all published and unpublished articles 
or book chapters written in English between January 1990 and July 2004, initially resulting in 
1357 potentially relevant studies.  We identified 77 additional studies by asking corresponding 
authors for any new or unpublished work comparing hospitals of different ownership forms. (See 
Figure 2 of Shen et al. 2005 for literature selection process) 
Study Selection. We selected studies of general, acute, short-stay hospitals in the United 
States that used multivariate analysis to study hospital performance.  The hospital sample had to 
include hospitals from at least two of our three included ownership forms (government-owned, 
private not-for-profit and private for-profit). We excluded studies that only compared sub-
categories of ownership (such as religious vs. secular private not-for-profits) or focused on 
hospitals of the Department of Veterans Affairs.  From the 340 studies fitting these selection 
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criteria, we further narrowed down the field to studies examining one or more of the following 
outcomes: financial performance; patient outcomes (mortality, complications, and other adverse 
outcomes); uncompensated care, unprofitable services or other measures of community benefits; 
or staffing. Two authors (Eggleston and Shen) independently applied these selection criteria, 
achieving 7% discrepancy in coding, with consensus resolution of all differences. From the 169 
citations that fell within this outcome scope, we excluded duplicates (such as dissertations and 
subsequently published papers), studies with very small sample sizes (fewer than 50 hospitals), 
and studies that did not report needed data (e.g., ownership coefficients in a regression) and for 
which authors were unable to supply that data.  
Through this search and selection process, we identified 141 studies. In this paper, we 
report results from analysis of the 46 studies in two broad categories: 31 studies of patient 
outcomes; and 15 studies of uncompensated care, unprofitable services, or other measures of 
community benefits (henceforth referred to jointly as “unprofitable care”). We include the 
complete bibliography of the included studies in the appendix. 
Data extraction.  We extracted data needed to construct measures of treatment effect and 
to test our pre-specified hypotheses about underlying sources of heterogeneity in studies of 
hospital ownership.  The data fields included each study’s data sources; sampling frame (covered 
years, covered regions, number of hospitals and patients); detailed outcome definition(s); and the 
ownership coefficients and their associated statistics (such as standard errors, degrees of freedom 
of the empirical model, etc).  Not all studies report the necessary statistics.  For example, many 
policy journals report only the significance level of the coefficient.  We contacted the 
corresponding authors to get the exact t-statistics where possible.  In cases where we could not 
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get the exact number, we estimate the t-statistic by generating a random number within the 
reported significance range. 
We coded each study’s analytic methods using binary variables for whether the study 
included the following information: patient demographic characteristics; co-morbidities; 
hospital-level characteristics (such as bed size, share of Medicare and/or Medicaid admissions); 
market-level characteristics (such as per capita income, population size, concentration or 
competitiveness measures); and cross-sectional or panel data estimation methods. We also coded 
whether ownership variables were only included as control variables and not the main research 
question of the study, and whether the analyses explicitly address ownership conversion. 
During the study design process we recruited and surveyed an expert panel of thirteen 
prominent researchers in the area of hospital ownership and performance who provided input on 
the research design.  
 
Statistical Methodology 
The 47 studies analyze diverse dependent variables. Even within a narrowly defined 
category (such as mortality), some dependent variables are measured as continuous variables at 
the hospital-level; others are dichotomous outcomes at the patient level. In order to have a 
standardized measure of ownership effect, we use the partial correlation coefficient to define 
each study’s effect size based on statistics that are commonly reported in published studies (t-
statistic and degrees of freedom), standardized using the Fisher transformation.4  The partial 
correlation coefficient describes the relationship between the dependent variable and the 
ownership variable, holding other variables constant.  It measures the correlation between a 
given ownership form and performance measure, controlling for the effect of covariates.     
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Explaining Variation in Study Results Using Meta-Regression Analysis. We 
employed random-effects meta-regression analysis to quantify to what extent various study 
characteristics account for heterogeneity of findings.5  The dependent variable is the standardized 
effect size from each study. Empirical features of each study serve as explanatory variables.  The 
regression model is necessarily parsimonious, given the limited number of studies in each 
category and the collinearity of many study features (such as data source and region covered).   
We hypothesized that several factors might account for a substantial fraction of between-
study variation in findings of patient outcomes.  First, studies vary in the outcome analyzed (e.g., 
heart condition mortality vs. all-cause mortality) and in their unit of analysis: some use patient-
level data, while others use aggregate data at the hospital level.  We group studies according to 
the unit of their observations.  Second, ownership differences might be affected by whether 
studies examine short-term or long-term mortality rates.  Third, studies vary by the type of 
confounding factors they control for in the regression.  Some studies were able to control for co-
morbidities, while others did not. Fourth, we hypothesized that results might be driven by the 
underlying data sources: studies using Medicare claims might produce different results from 
those using all-payer data.  Lastly, the variation in results might also be explained by the covered 
periods of the study and/or the regions studied. We also examined correlations among these 
individual factors. Limited sample size and collinearity precluded including all the hypothesized 
explanatory variables simultaneously. 
For unprofitable care, we had even fewer studies, and all at the hospital level. Moreover, 
the analytical issues in unprofitable care are different from those of patient outcomes; market 
conditions are likely to play an even larger role. We categorize studies according to how they 
model market competition.  Based on the theoretical and empirical literature, we hypothesize that 
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studies not explicitly accounting for hospital market competition are likely to find larger 
ownership differences than those that explicitly model hospital competition (for example, by 
implementing a selection model) or those that employ panel data estimation methods to 
minimize the unobserved heterogeneity across markets.  We also explore whether regional 
differences explain heterogeneous results.    
Overlapping samples problem. Conventional meta-analyses combine results from 
mutually exclusive patient populations. Yet many studies we reviewed analyze the same set of 
hospitals – and potentially the same patient outcomes – in overlapping years.  There are fewer 
than 6000 hospitals in the United States; many hospital studies analyze national samples, and 
most use one or more of a few common data sources (Medicare claims or state-specific 
administrative data).  For example, among the 31 patient outcome studies, the median hospital 
sample size per year is 1378.  In another example, of the studies using Medicare claims data 
comparing private hospitals, almost three-quarters use data spanning both the 1980s and 1990s 
that is representative of hospitals from the whole country, suggesting significant overlap. 
Our effect size measures, defined by partial correlation coefficients, should remain valid 
when observations are correlated.6 However, the studies do not represent independent samples, 
and statistical power will not increase proportionally with each additional study’s sample size.  
Thus, unlike most meta-analyses with independent samples, we do not report the combined 
effect size from the random-effects analyses.  Our focus instead is on what explanatory variables 
help to account for the wide variation in study results.  
Publication bias. We looked for evidence of publication bias by examining the 
relationship between the absolute value of t-statistics and the square root of degrees of freedom7 
as well as the traditional funnel plot; we do not find evidence of publication bias.   
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III. Results  
Exhibit 1 summarizes our included studies. The 31 studies of patient outcomes include 
several analyzing multiple outcomes. 24 analyze short-term mortality (patient follow-up period 
less than 180 days), 6 analyze long-term mortality rates (including 5 that also analyzed short-
term mortality), and 13 analyze other adverse patient outcomes, such as surgical complications 
or medical errors. We also review 15 studies on measures of unprofitable care: 9 analyze 
uncompensated care (charity care plus bad debt); 6 analyze unprofitable services; and 2 analyze a 
broader metric of community benefits (e.g., including services to public program beneficiaries, 
outreach efforts, etc.).  Most studies of patient outcomes are representative of the entire United 
States, but more than half of the studies comparing private nonprofit and for-profit 
uncompensated care use data from California or Florida.  Hospital sample sizes are often quite 
large, especially for studies using panel data, suggesting that many studies analyze the same 
hospitals in similar time periods.  Many hospital-level analyses do not report patient sample sizes.  
The effect sizes and their confidence intervals from random-effects models for patient 
outcomes and unprofitable care appear in Exhibits 2 and 3, respectively.  In each case, Exhibit A 
summarizes studies comparing for-profits to private not-for-profits, and Exhibit B summarizes 
studies comparing government hospitals to private not-for-profits.  A positive effect size 
indicates that for-profits (or government hospitals) are associated with a higher level of adverse 
events or unprofitable care, compared to private not-for-profit hospitals. The majority of studies 
find no statistically significant difference between not-for-profit and for-profit hospitals in 
mortality or other adverse events.  Exhibit 2B illustrates that most studies that used nationally 
representative data find government hospitals to have higher short-term mortality rates than 
private not-for-profits, but less difference in long-term mortality or other adverse events.  Exhibit 
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3A shows that most studies find either no difference or for-profit hospitals provide less 
unprofitable care than not-for-profits do.  Exhibit 3B shows that studies using panel data 
estimation methods consistently find no difference between not-for-profit and government 
hospitals, whereas studies using cross-sectional data and methods have wider variation in sign 
and magnitude of their effect sizes.  
In all cases the chi-square test for heterogeneity clearly rejects the null hypothesis that 
our combined studies are a homogeneous set (data not shown), thus validating our approach of 
using random effects regression models in our meta-regressions.  Similar to studies of ownership 
and other aspects of performance8, a plot of sample size and t-statistics does not reveal a pattern 
of t-statistics hovering around 2 regardless of sample size (not shown).  Thus, we find no 
evidence of publication bias. 
 
Explaining Variation in Studies Examining Patient Outcomes 
Exhibit 4 presents our meta-regression results for variation in studies examining patient 
outcomes.  Each panel represents a separate regression, since we have too few studies and too 
much correlation among some explanatory factors to include them all in one meta-regression.  A 
positive coefficient indicates that for-profits (or government hospitals) are associated with a 
higher rate of adverse events than private not-for-profit hospitals. Note that the number of 
observations in the meta-regression does not correspond perfectly with that in the figures; the 
figures plot a single point for each study (e.g., averaging effect sizes across years if the study 
reported separate results for multiple years), whereas the meta-regressions use the separate 
estimates from such studies. 
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We first consider whether differences in type of patient outcome can explain variations in 
study findings about ownership.  For comparisons between not-for-profit and for-profit hospitals, 
the estimated constant term indicates no statistically significant difference between private not-
for-profits and for-profits for the 48% of studies analyzing all-cause mortality, the reference 
group.  The 21% of studies analyzing all-cause patient outcomes other than mortality also find no 
difference. The remaining studies that focus on heart conditions find for-profits to have higher 
rates of adverse outcomes at a 5% level of significance.  The low I-squared indicates that 
accounting for categories of patient outcome helps to explain significant heterogeneity across 
studies – in this case, the covariates explain 67% of the variation. 
 For comparisons of government hospitals to not-for-profits, the half of studies analyzing 
all-cause mortality (the reference group) is associated with a strongly significant finding of 
higher government mortality or other adverse events (with a magnitude more than twice that 
found for heart-disease studies comparing for-profits to not-for-profits).  Studies of heart 
conditions (22% on mortality and 11% on adverse outcomes) found higher rates of adverse 
events in government hospitals, although the quality gap is smaller (adding the coefficient to the 
reference group/constant of 0.046 yields about 0.023).  Studies of all-cause patient outcomes 
other than mortality find essentially no difference between private not-for-profit and government 
hospitals.  
The second set of meta-regressions reported in Exhibit 4 examines the proportion of 
heterogeneity explained by different studies’ level or unit of analysis.  For comparisons of 
private hospitals, the estimated constant term indicates no statistically significant difference 
between not-for-profits and for-profits for the 29% of studies with patient-level analyses, the 
reference group.  Hospital-level analyses yield a point estimate of worse for-profit quality, but 
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the coefficient does not reach statistical significance at conventional levels.  The remaining 40% 
of studies utilize both patient- and hospital- level analyses.  This category refers to studies in 
which the hospital-level dependent variable is constructed from a regression using patient-level 
data, to control for confounding from patient demographics.  Such combined-level analyses find 
worse for-profit quality, with the same point estimate as for hospital-level analyses, now 
statistically significant at the 10% level.  
Patient-level analyses also suggest no statistically significant difference between not-for-
profit and government hospitals, whereas hospital-level analyses find government hospitals 
associated with higher mortality and other adverse events.  Studies using a combination of 
patient- and hospital-level data also find government hospitals associated with lower quality; this 
latter effect is significant at the 2% level, but about half the magnitude of the hospital-only 
analyses, indicating that both-level analyses find less of a quality gap between government 
hospitals and not-for-profits than hospital-level analyses do. 
The third set of meta-regressions test the hypothesis that differences in patient follow-up 
period explain heterogeneity of study results.  Studies of mortality usually specify whether 
patient follow-up was only in-hospital or was all-location (e.g., linking patients to death 
certificates) for a specific period of time, such as 30 days post-admission.  Studies of other 
adverse events seldom report when the adverse event occurs.  For private hospitals, none of these 
categories are associated with a statistically significant difference between private not-for-profits 
and for-profits.  
For studies including a comparison of private not-for-profit and government hospitals, the 
56% of studies using in-hospital and unspecified period of patient follow-up find government 
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hospitals associated with significantly higher mortality and rates of other adverse events.  Studies 
examining other categories of patient follow-up do not differ statistically from that result.  
In the next panel, we test our hypothesis that data sources might explain a significant 
proportion of between-study heterogeneity.  Studies using the National Long Term Care Survey 
find not-for-profits associated with lower quality than for-profits.  Studies using Medicare or 
other data sources tend to find no statistically significant difference between private not-for-
profits and for-profits.  For private not-for-profit and government hospitals, the 72% of studies 
using Medicare claims are associated with findings of lower quality in government-owned 
hospitals, although the difference is not statistically significant at conventional levels.  
In testing the hypothesis for co-morbidity adjustment, we find that the one-third of 
studies with no co-morbidity information find statistically significant higher rates of mortality 
and other adverse events in for-profit hospitals.  By contrast, the two-thirds of studies that 
explicitly control for confounding from patient co-morbidities are associated with no statistically 
significant difference between not-for-profits and for-profits.  Studies comparing private not-for-
profit and government hospitals find government hospitals associated with higher mortality and 
rates of other adverse events, with an even larger quality gap in the half of studies that adjust for 
co-morbidities.  Note that including patient co-morbidity information is positively correlated 
with some weakness in study design—most of these are studies that examined only in-hospital or 
unspecified patient follow-up period and have data only from the 1980s. Differences in covered 
periods also explain some heterogeneity; more recent data is generally associated with fewer 
ownership differences in patient outcomes.  For private hospitals, a meta-regression reveals that 
studies using data only from the 1980s and studies that use data spanning the 1980s and 1990s 
consistently report lower for-profit quality.  The 35% of studies using data from the 1990s 
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forward are associated with virtually no difference between private not-for-profits and for-profits, 
although that coefficient is only borderline significant at conventional levels.  
Among studies that included government hospitals, studies using data only from the 
1980s find higher mortality and rates of other adverse events in government hospitals (0.021 + 
0.032 = 0.053, about the same magnitude as that associated with hospital-level analyses).  
Studies spanning the 1980s and 1990s find a smaller quality gap (by about 50%), and studies 
using 1990s or more recent data do not differ statistically from those spanning the 1980s and 
1990s.  
Overall, these study features explain a substantial portion of the heterogeneity across 
studies (as measured by the I-squared).  We also examined whether disciplinary focus or 
publication outlet helps to explain divergent study findings.  A meta-regression found no 
statistically significant differences in standardized effect sizes of studies published in medical 
journals (38%), economics journals (33%), or policy journals (29%). There were also no 
statistically significant differences among regions covered in the patient outcome studies.  
Finally, we found no systematic differences in estimated ownership effects between studies that 
did and did not examine ownership conversions. (All meta-regression results are available from 
the authors upon request.) 
 
Explaining Variation in Studies Examining Unprofitable Care 
 Fewer of our hypothesized factors explain a significant proportion of between-study 
variation in studies of unprofitable care.  Exhibit 5 presents results from the three sets of meta-
regressions that do seem to have some explanatory power for understanding diverse findings in 
the literature.   First consider the type of unprofitable care examined.  For private hospital 
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comparisons, analyses of uncompensated care find for-profits provide less, and analyses of 
unprofitable services or broader measures of community benefits do not differ significantly in 
their overall findings (i.e., they also find for-profits provide less).  For studies including 
government hospitals, the one-third analyzing uncompensated care finds that government 
hospitals provide more than private not-for-profits (significant at the 5% level and with a 
magnitude of more than twice the difference among private hospitals).  The other two-thirds of 
studies, examining unprofitable services or community benefits, are associated with a reverse 
effect, implying that private not-for-profits supply slightly more such services than their 
government counterparts.  
How studies empirically account for hospital competition provides additional insight 
regarding diversity of study findings.  About 50% of studies do not explicitly model hospital 
competition (although most of them do include some market characteristics as independent 
variables).  A quarter of the studies explicitly model hospital competition either through selection 
models or a more sophisticated procedure to define hospital markets. About a third of the studies 
use panel data and employ fixed-effect or random-effect models to minimize potential estimation 
bias due to unobserved market heterogeneity.  The second panel of Exhibit 5 shows that studies 
with no explicit treatment of hospital competition tend to find that for-profit hospitals provide 
significantly less unprofitable care than nonprofits do (-0.07; p<0.05).  The ownership gap is 
much smaller when estimated by studies that model competition explicitly or use panel data 
estimation methods; such studies essentially find no difference between not-for-profit and for-
profit hospitals in provision of unprofitable care.  For studies comparing not-for-profit and 
government hospitals, there is no significant difference in effect sizes among these three types of 
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studies, partly because so few studies compare unprofitable care provided by not-for-profit and 
government hospitals.   
Finally, the last panel of Exhibit 5 reports a meta-regression on covered regions. Studies 
using California data find that for-profits provide just as much if not more unprofitable care than 
their private nonprofit counterparts (-0.048 + 0.086=0.038).  Note that this “California effect” 
emerges despite a positive correlation between California data and two study features associated 
with for-profits providing less than nonprofits: analysis of uncompensated care (compared to 
broader measures of community benefits) and including ownership only as a control variable 
(compared to ownership differences being a study’s primary research question).  By contrast 
with California, studies of Florida data find for-profits provide significantly less unprofitable 
care (-0.136).  Almost half of studies use data that is representative of the US as a whole or is 
specific to other combinations of states; those studies are associated with for-profits providing 
significantly less unprofitable care than private not-for-profit hospitals do (-0.048).  Meta-
regressions using our other hypothesized explanatory variables (e.g., time period covered) find 
no statistically significant effects.  Overall, the study features we examined explained much less 
of the heterogeneity across unprofitable care studies than they did for studies of patient benefits; 
in most cases, the I-squared is substantially higher than when we examine patient outcomes, and 
percentage explained compared to the null model (with no covariates) is much lower.  
 
IV. Conclusions 
We conducted a systematic review of the empirical literature since 1990 to examine what 
factors explain the diversity of findings regarding hospital ownership and quality of care, as well 
as measures of community benefits. 
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Our meta-regression analyses revealed several correlates of study heterogeneity.  
Differences in analytic methods are the most salient. For studies of patient outcomes comparing 
not-for-profit and for-profit hospitals, study features that can explain most of the variation in 
effect sizes include disease or outcome studied, whether or not the study adjusted for patient co-
morbidities, and data sources.  For unprofitable care, how studies handle market competition in 
their empirical methods, as well as regional differences, account for substantial variation in 
results.  
Differences in the unit of analysis yield contrasting findings: patient outcomes do not 
statistically differ across all three ownership forms when analyses were done at the patient level, 
whereas hospital-level and combined-level analyses find the highest rates of mortality and other 
adverse events at government hospitals, lower rates at for-profits, and the lowest rates at private 
nonprofit hospitals.  We find that studies that do not adjust for co-morbidities tend to find a 
bigger gap between private not-for-profits and for-profits.  Including co-morbidities reduces 
estimates of the quality gap among private hospitals, while maintaining (or widening) the 
government-private nonprofit quality gap. It is important to note, however, that including patient 
co-morbidity information is positively correlated with in-hospital or unspecified patient follow-
up period and having data only from the 1980s (and negatively correlated with a focus on heart 
condition outcomes, a longer-term patient follow-up period, combined patient- and hospital-level 
analysis, and data spanning the 1980s and 1990s). Thus, including patient co-morbidities does 
not necessarily represent a “gold standard” in this literature.  
Studies of data from the 1980s (or spanning both the ‘80s and ‘90s) find more of a quality 
difference between for-profit and not-for-profit hospitals than studies using more recent data.  
Similarly, studies that examine data from before 1990 find the gap between private not-for-profit 
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and government-owned community hospitals to be substantially larger than studies that examine 
data from the 1990s.  These results are consistent with predictions of convergence among 
ownership forms in the increasingly competitive environment. Part of the time-trend toward 
finding fewer ownership differences with more recent data can also be explained by differences 
in analytic methods, since more recent studies often use methods specifically developed to 
control for confounding from market structure and unobserved differences in patient severity. 
The meta-regression allows us to disentangle regional differences in unprofitable care.  
Studies examining nationally representative samples, and of Florida in particular, tend to find 
for-profits provide less unprofitable care, whereas California for-profit hospitals seem to be 
providing comparable amounts as their private nonprofit counterparts.   
It is also worth noting what factors do not help to explain differences in study findings.  
For example, we found no systematic differences in estimated ownership effects between studies 
that did and did not examine conversions.  Similarly, regions covered explained little of the 
variation in studies of patient outcomes, and the time period of the data explained little variation 
among studies of uncompensated care and other measures of community benefits.  Analyses 
dropping outliers47 found fairly similar results to those reported here. (All such sensitivity 
analyses are available from the authors upon request.)  Although methods to detect publication 
bias are not perfect, it is not surprising that we found no evidence of publication bias—
theoretical predictions about ownership effects vary. 
Our results contrast with those of the sole previous systematic review in this area.9 
Whereas we aim to explain the heterogeneity in study results, the previous study aimed to 
provide a single definitive answer to the question of whether quality differs in for-profit and 
private not-for-profit hospitals.  Yet the nature of observational studies in this area severely 
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limits the ability of meta-analysis to achieve that goal: the studies not only are observational, but 
draw from overlapping samples, so that many studies include data from the same hospitals or 
even the same patients.  Although Devereaux et al. describe their review as including “fifteen 
observational studies, involving more than 26,000 hospitals,” there are actually fewer than 6000 
hospitals in the entire US.  The authors note that almost all studies draw from the same database, 
but do not mention that the studies therefore do not represent independent samples. Another 
reason for interpreting the single answer from Devereaux et al. with caution is that they use 
patient sample size to define confidence intervals, whereas ownership is a hospital-level 
characteristic.  Since there are many fewer hospitals than patients, using patient sample size 
yields a misleadingly precise estimate of hospital-level mortality differences and tends to give 
the largest weight to studies with the fewest controls for confounding factors (because authors 
often restrict sample size specifically to remove residual confounding from case mix or market 
characteristics).   
Our paper also has several limitations.  First, the tremendous diversity of dependent 
variable definitions and analytic methods (e.g., dichotomous and continuous, risk differences and 
relative risks) preclude using a more interpretable definition of effect size that would be 
comparable across studies.  The standardized effect size that we use provides less intuitive 
interpretation of the ownership effect for clinical or policy decisions.  However, by the 
conventional Cohen standard10, magnitudes of our effect sizes mostly fall into what is considered 
the “small” effect region (r<0.10), indicating that ownership appears to play a much less 
important role in influencing hospital performance than other hospital characteristics, even when 
it is a significant predictor.  Second, although we identified far more studies than many 
systematic reviews do, the limited number as well as substantial collinearity among study 
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features preclude controlling for all the hypothesized determinants of study heterogeneity in the 
same meta-regression (correlation matrices among study features are included in the Appendix).  
Finally, we discuss here only a few key aspects of hospital performance, rather than a 
comprehensive overview of all potential differences by organizational form.  Although we 
examine potential systematic differences in studies that control for market-level factors, we do 
not focus on market-level spillover effects among hospitals of differing ownership forms.  Others 
have argued that such spillover effects can be very important, and that for-profit providers might 
substantially raise the overall “cost-effectiveness” or productivity of service delivery through 
such mechanisms.11 
Policymakers and researchers seeking to interpret the literature on hospital ownership and 
quality of care (or community benefits) should be aware that findings differ significantly 
according to the analytic methods of individual studies, and that conventional methods of meta-
analytic synthesis are inappropriate given the considerable overlap among studied hospitals. 
Moreover, there appears to be as much, if not more, heterogeneity among hospitals of the same 
ownership form as across ownership forms.  Future research on the determinants of this variation 
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patients Ownership forms 
studied
Al-Haider1991 X US 1984 243 N/A N,F
Bond1999 X US 1992 3763 N/A N,F,G
Brennan1991 X NY 1984 51 31429 N,F,G




Deily2004 X FL 1999 -- 2001 416 N,F,G
Ettner2001 X US 1990 2349 42420 N,F
Farsi2004 X X CA 1990 -- 1998 1522 249332 N,F*
Geweke2003 X Los Angeles 
County
1989 -- 1992 114 74848 N,F,G
Gowrisankaran1999 X 3 South CA 
counties
1989 -- 1994 844 178972 N,F,G
Keeler1992 X 5 states 1985 -- 1986 297 6665 N,F,G
Kessler2002 X X MSA 1985 -- 1996 29388 1661674 N,F,G
Kuhn1994 X X US 1988 3782 N/A N,F,G
Lanska1998a X X US 1993 900 18510 N,F,G
Lanska2000 X 17 states 1993 -- 1994 900 1408015 N,F,G
Lee2002 X X US 1997 358 N/A N,F
Manheim1992 X US 1987 3796 N/A N,F,G
McClellan2000b X US 1985, 1991, 1994 11154 >600 000 N,F,G
Mukamel2001 X 134 MSAs 1990 1927 N/A N,F,G
Norton1998 X US 1985 -- 1990 295473 N,F,G
Picone2002 X X US 1984 -- 1995 40095 73503 N,F,G*
Pitterle1994 X US 1988 4864 N/A N,F,G
Shen2002 X X X US 1985 -- 1994 16042 2100000 N,F*
Sloan1999 X US 1982, 1984, 1989, 1995 1378 2674 N,F,G
Sloan2001 X X US 1982, 1984, 1989, 1995 1378 8403 N,F,G
Sloan2002 X X 21 states 1988 -- 1996 1215 417851 GN,F*
Sloan2003 X X US 1994 -- 1995 129092 N,F,G
Slonim2003 X US 1988, 1991, 1994, 1997 759 2483216 N,F,G
Taylor1999 X US 1982, 1984, 1989, 1995 1378 2674 N,F,G
Unruh2000 X X PA 1991--1997 1477 13257906 N,F
Wan1992 X VA 1987 85 N/A N,F
Yuan2000 X US 1984 -- 1993 5127 N/A N,F,G
Total 24 6 13
















patients Ownership forms 
studied
Campbell1993 X CA 1983, 1987 311 N/A N,F,G
Clement2002 X CA 1996 350 N/A N,F,G
Currie2004 X CA 1988 -- 1996 3528 N/A N,F,G
Kwon1999 X MO 1992 123 N/A N,F
Molinari1993 X CA 1985 188 N/A N,F,G
Needleman1999 X FL 1981 -- 1996 2728 N/A N,F,G*
Norton1994 X US 1981 3322 N/A N,F
Potter2001 X US 1980, 1985, 1990, 1994 19444 N/A N,F,G
Proenca2003 X US 1997 3453 N/A N,F
Shen2003b X US 1987 -- 1998 8915 N/A N,F,G*
Shukla1997 X VA 1993 83 N/A N,F
Thorpe2000 X X US 1990 -- 1997 431 N/A N,F,G*
Thorpe2001 X MSA 1991 -- 1997 21000 N/A N,F,G
Young1999 X X CA, FL, TX 1978 -- 1995 1368 N/A N,F*
Zeckhauser1995 X CA, FL 1982, 1990 908 N/A N, F, G
Total 9 6 2
Notes:
MSA=metropolitan statistical areas; N/A=Not available
* Studies of ownership conversion
  
Exhibit 2. Summary of Effect Sizes For Patient Outcomes 
2A. Studies Comparing Not-For-Profit and For-Profit Hospitals 
 
 Effect size
 -.3  -.2  -.1  0  .1  .2  .3
 Study  Effect size (95% CI)  % Weight
 1. short-term mortality 
 al-haider1991   0.05 (-0.08, 0.17)   0.4 
 bond1999   0.01 (-0.02, 0.04)   5.4 
 brook1990   0.00 (-0.28, 0.29)   0.1 
 deily2004  -0.00 (-0.10, 0.10)   0.7 
 farsi2004   0.00 (-0.05, 0.05)   2.5 
 geweke2003  0.00 (-0.19, 0.19)   0.2 
 gowrisankaran1999   0.00 (-0.06, 0.07)   1.4 
 keeler1992   0.08 (-0.03, 0.20)   0.5 
 kuhn1994   0.01 (-0.02, 0.04)   5.4 
 lanska1998a  -0.00 (-0.07, 0.06)   1.5 
 lee2002   0.00 (-0.10, 0.11)   0.6 
 manheim1992   0.00 (-0.03, 0.04)   5.5 
 mcclellan2000b   0.02 ( 0.00, 0.04)  11.7
 mukamel2001  -0.06 (-0.11,-0.02)   3.1 
 picone2002  -0.00 (-0.01, 0.01)  20.5
 pitterle1994   0.01 (-0.01, 0.04)   6.6 
 shen2002   0.03 ( 0.01, 0.05)  11.3
 sloan1999  -0.01 (-0.07, 0.04)   2.2 
 sloan2001  -0.01 (-0.07, 0.04)   2.2 
 sloan2002   0.00 (-0.06, 0.06)   2.0 
 sloan2003  -0.00 (-0.04, 0.03)   4.5 
 taylor1999  -0.02 (-0.07, 0.04)   2.2 
 unruh2000   0.04 (-0.01, 0.09)   2.4 
 yuan2000   0.03 (-0.00, 0.05)   6.9 
    100.0 
 2. long-term mortality 
 kessler2002   0.01 (-0.03, 0.05)  13.6
 kuhn1994   0.04 ( 0.01, 0.07)  15.9
 picone2002  -0.00 (-0.01, 0.01)  25.5
 shen2002   0.04 ( 0.02, 0.06)  21.6
 sloan2001  -0.00 (-0.05, 0.05)   9.2 
 sloan2003  -0.00 (-0.04, 0.03)  14.3
   100.0 
 3. other patient outcomes
 brennan1991  -0.00 (-0.29, 0.28)   0.3 
 ettner2001  -0.00 (-0.04, 0.04)  10.3
 farsi2004   0.00 (-0.05, 0.05)   7.6 
 kessler2002   0.00 (-0.04, 0.04)  11.2
 lanska1998b  -0.02 (-0.16, 0.12)   1.3 
 lanska2000  -0.00 (-0.07, 0.06)   5.1 
 lee2002   0.18 ( 0.08, 0.29)   2.2 
 norton1998   0.01 (-0.01, 0.02)  22.4
 shen2002   0.03 ( 0.01, 0.05)  20.5
 sloan2002   0.00 (-0.05, 0.06)   6.5 
 slonim2003  -0.01 (-0.04, 0.03)  12.1
 wan1992  -0.08 (-0.30, 0.13)   0.6 
    100.0 
FP has higher rates of adverse events FP has lower rates of adverse events 
  
Exhibit 2B. Studies Comparing Outcomes at Not-For-Profit and Government Hospitals 
 
 
  Effect size
 -.3  -.2  -.1 0  .1  .2  .3
 Study  Effect size (95% CI) % Weight 
 1. short-term mortality 
 bond1999   0.07 ( 0.04, 0.10)  11.4 
 deily2004  -0.00 (-0.10, 0.09)   2.3 
 geweke2003   0.01 (-0.18, 0.20)   0.7 
 keeler1992   0.05 (-0.07, 0.16)   1.7 
 lanska1998a  -0.01 (-0.07, 0.06)   4.5 
 manheim1992   0.06 ( 0.03, 0.10)  11.4 
 mcclellan2000b   0.02 ( 0.00, 0.04)  16.8 
 mukamel2001   0.03 (-0.02, 0.07)   7.8 
 pitterle1994   0.06 ( 0.03, 0.08)  12.8 
 shen2002   0.02 (-0.00, 0.03)  17.8 
 yuan2000   0.03 ( 0.01, 0.06)  13.1 
 Subtotal   0.04 ( 0.02, 0.05) 100.0 
 2. long-term mortality 
 kessler2002   0.01 (-0.02, 0.05)  15.6 
 shen2002   0.03 ( 0.01, 0.04)  84.4 
 Subtotal   0.02 ( 0.01, 0.04) 100.0 
 3. other patient outcomes
 brennan1991  -0.00 (-0.28, 0.28)   0.2 
 kessler2002   0.00 (-0.04, 0.04)  11.0 
 norton1998   0.00 (-0.01, 0.02)  38.6 
 shen2002   0.03 ( 0.01, 0.04)  37.9 
 slonim2003  -0.00 (-0.04, 0.03)  12.2 
 Subtotal   0.01 (-0.00, 0.03) 100.0 
GOV has higher rates of adverse events GOV has lower rates of adverse events 
  
Exhibit 3. Summary of Effect Sizes For Unprofitable Care 
3A. Studies Comparing Not-For-Profit and For-Profit Hospitals 
 
 
Exhibit 3B. Studies Comparing Not-For-Profit and Government Hospitals 
 
  
  Effect size
 -.5  0  .5
 Study 
 Effect size
 (95% CI)  % Weight
Use cross-sectional analysis methods
 potter2001  -0.07 (-0.09,-0.06)  25.5 
 clement2002   0.01 (-0.10, 0.11)  24.8 
 molinari1993   0.13 (-0.02, 0.27)  24.3 
 thorpe2001   0.45 ( 0.41, 0.48)  25.4 
      100.0 
 Use panel-data analysis methods 
 currie2004   0.00 (-0.03, 0.03)   5.6 
 shen2003b   0.00 (-0.02, 0.02)  18.6 
 thorpe2000   0.01 ( 0.00, 0.03)  37.9 
 thorpe2000   0.01 ( 0.00, 0.03)  37.9 
     100.0 
  Effect size
 -.5  0  .5
 Study  Effect size (95% CI)  % Weight
 1. Uncompensated care
 campbell1993  -0.00 (-0.08, 0.08)   9.2 
 clement2002   0.01 (-0.09, 0.12)   8.2 
 kwon1999   0.00 (-0.17, 0.18)   5.4 
 molinari1993   0.08 (-0.06, 0.22)   6.6 
 needleman1999  -0.07 (-0.11,-0.03)  10.6 
 thorpe2000 (cross-sectional analysis)  -0.02 (-0.03,-0.00)  11.0 
 thorpe2000 (conversion analysis)  -0.01 (-0.02,-0.00)  11.1 
 thorpe2001  -0.33 (-0.37,-0.30)  10.7 
 young1999  -0.03 (-0.08, 0.02)  10.2 
 zeckhauser1995 (CA hospitals)   0.02 (-0.06, 0.10)   9.2 
 zeckhauser1995 (FL hospitals)  -0.27 (-0.38,-0.15)   7.8 
  100.0 
 2. Unprofitable care and community benefits 
 norton1994  -0.00 (-0.03, 0.03)  15.4 
 potter2001  -0.04 (-0.06,-0.03)  18.7 
 proenca2003  -0.01 (-0.04, 0.03)  15.5 
 shen2003b   0.04 ( 0.02, 0.06)  18.2 
 shukla1997  -0.21 (-0.43, 0.00)   1.6 
 thorpe2000  -0.01 (-0.03,-0.00)  18.9 
 young1999   0.00 (-0.05, 0.06)  11.7 
  100.0 
FPs provide less charity care  FPs provide more charity care 
GOV provides less charity care  GOV provides more charity care 
Exhibit 4. Meta Regression Results: Variation in Studies Examining Patient Outcomes
For-profits Compared to Nonprofits Government Compared to Nonprofits
Study Features
Share of Studies 











All-cause mortality (reference group) 48% 0.003 0.004 50% 0.047 ** 0.008
Heart-condition mortality 24% 0.017 ** 0.006 22% -0.024 ** 0.009
All-cause patient outcomes other than mortality 21% 0.003 0.008 17% -0.045 ** 0.012
Heart-condition outcomes other than mortality 7% 0.020 * 0.009 11% -0.023 * 0.012
Proportion of variation due to heterogeneity (I-square) 0.083 0.00
Level of analysis
Patient-level analysis (reference group) 29% -0.001 0.007 22% 0.002 0.007
Hospital-level analysis 31% 0.015 0.010 33% 0.048 ** 0.010
Both patient- and hospital-level 40% 0.016 * 0.008 44% 0.023 ** 0.009
Proportion of variation due to heterogeneity (I-square) 0.24 0.00
Patient follow-up period
In-hospital and unspecified (reference group) 60% 0.003 0.006 56% 0.030 ** 0.008
Short-term not including in-hospital (<180 days) 19% 0.011 0.008 22% -0.007 0.012
Long-term (>= 180 days) 21% 0.014 0.008 22% -0.006 0.012
Proportion of variation due to heterogeneity (I-square) 0.26 0.43
Data sources
Other data sources (reference group) 26% 0.004 0.007 28% -0.002 0.016
Medicare claims 60% 0.014 0.008 72% 0.030 0.017
National Long Term Care Survey 14% -0.021 ** 0.005 0%
Proportion of variation due to heterogeneity (I-square) 0.00 0.35
Risk adjustment with patient co-morbidities
No comorbidity information (reference group) 33% 0.020 ** 0.004 50% 0.019 ** 0.006
Study includes comorbidity information 67% -0.017 ** 0.005 50% 0.020 * 0.010
Proportion of variation due to heterogeneity (I-square) 0.07 0.39
Covered period
Data from 1980s and 1990s (reference group) 43% 0.014 ** 0.004 50% 0.021 ** 0.005
Data from 1980s only 22% 0.003 0.010 24% 0.032 ** 0.013
Data from 1990s only 35% -0.014 0.008 26% 0.009 0.013
Proportion of variation due to heterogeneity (I-square) 0.24 0.24
Number of observations 50 26
* p<0.10 ** p<0.05
Note: Each panel represents a separate regression; a positive coefficient indicates that for-profit (or government) hospitals are associated with a 
higher level of that dependent variable than private not-for-profit hospitals. The significance test was obtained using the permutation test 
approach in Higgens and Thompson (2004) to avoid spurious findings. The I2 for the null model with no covariates is 0.252 for studies 
comparing nonprofits and for-profits, and 0.405 for studies comparing nonprofits and government hospitals.
**
*
Exhibit 5. Meta Regression Results: Variation in Studies Examining Unprofitable Care















Uncompensated care (reference group) 56% -0.061 * 0.028 33% 0.156 ** 0.062
Unprofitable services or community benefits 44% 0.043 0.039 67% -0.191 ** 0.075
Proportion of variation due to heterogeneity (I-square) 0.94 0.98
Type of estimation model
No explicit model of market competition nor 
panel estimation (reference group) 52% -0.077 * 0.026 50% 0.044 0.063
Explicit modeling for market competition 24% 0.073 * 0.043 25% -0.020 0.113
Use panel data estimation 32% 0.052 0.038 42% -0.030 0.099
Proportion of variation due to heterogeneity (I-square) 0.92 0.99
Covered region 
US representative and others (reference group) 48% -0.048 * 0.023 75% 0.020 0.051
California 32% 0.086 * 0.042 25% 0.021 0.105
Florida 20% -0.089 * 0.048 0%
Proportion of variation due to heterogeneity (I-square) 0.94 0.99
Number of observations 25 12
* p<0.10 ** p<0.05
Note: Each panel represents a separate regression; a positive coefficient indicates that for-profits (or government) are associated with a 
higher level of that dependent variable than private not-for-profit hospitals. The significance test was obtained using the permutation test 
approach in Higgens and Thompson (2004) to avoid spurious findings. The I2 for the null model with no covariates is 0.938 for studies 
comparing nonprofits and for-profits, and 0.985 for studies comparing nonprofits and government hospitals.
Appendix A1. Correlation Matrix of Study Features For Outcome Studies
Studies comparing NFP and FP 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
1. All-cause mortality 1.00
2. Heart-condition mortality -0.53 1.00
3. All-cause patient outcomes other than mortality -0.50 -0.29 1.00
4. Heart-condition outcomes other than mortality -0.26 -0.16 -0.14 1.00
5. In-hospital and unspecified 0.20 -0.45 0.31 -0.15 1.00
6. Short-term not including in-hospital (<180 days) 0.02 0.30 -0.25 -0.13 -0.59 1.00
7. Long-term (>= 180 days) -0.27 0.25 -0.13 0.31 -0.63 -0.25 1.00
8. Patient-level analysis -0.60 0.27 0.44 0.03 -0.12 -0.04 0.18 1.00
9. Hospital-level analysis 0.50 -0.37 -0.10 -0.19 0.24 -0.06 -0.22 -0.42 1.00
10. Both patient- and hospital-level 0.09 0.11 -0.31 0.15 -0.11 0.09 0.04 -0.52 -0.55 1.00
11. Medicare claims 0.11 0.12 -0.28 0.04 -0.48 0.28 0.31 -0.12 0.13 -0.01 1.00
12. National Long Term Care Survey 0.16 0.09 -0.21 -0.11 -0.22 0.15 0.12 0.04 -0.27 0.22 0.34 1.00
13. Study includes comorbidity information 0.07 -0.08 0.12 -0.20 0.24 -0.04 -0.25 0.22 0.15 -0.34 -0.17 0.14 1.00
14. Data from 1980s and 1990s -0.06 0.19 -0.22 0.13 -0.36 0.19 0.25 -0.12 -0.48 0.56 0.32 0.47 -0.31 1.00
15. Data from 1980s only 0.18 -0.16 0.04 -0.15 0.09 0.03 -0.14 -0.05 0.39 -0.32 0.29 -0.22 0.10 -0.46 1.00
16. Data from 1990s only -0.10 -0.06 0.19 -0.01 0.30 -0.23 -0.14 0.17 0.15 -0.30 -0.59 -0.30 0.23 -0.64 -0.39 1.00
Studies comparing NFP and GOV 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
1. All-cause mortality 1.00
2. Heart-condition mortality -0.53 1.00
3. All-cause patient outcomes other than mortality -0.45 -0.24 1.00
4. Heart-condition outcomes other than mortality -0.35 -0.19 -0.16 1.00
5. In-hospital and unspecified 0.45 -0.60 0.40 -0.40 1.00
6. Short-term not including in-hospital (<180 days) 0.00 0.36 -0.24 -0.19 -0.60 1.00
7. Long-term (>= 180 days) -0.53 0.36 -0.24 0.66 -0.60 -0.29 1.00
8. Patient-level analysis -0.53 -0.29 0.84 0.24 0.21 -0.29 0.04 1.00
9. Hospital-level analysis 0.71 -0.38 -0.32 -0.25 0.40 -0.09 -0.38 -0.38 1.00
10. Both patient- and hospital-level -0.22 0.60 -0.40 0.04 -0.55 0.33 0.33 -0.48 -0.63 1.00
11. Medicare claims -0.12 0.33 -0.39 0.22 -0.55 0.33 0.33 -0.27 0.18 0.06 1.00
12. National Long Term Care Survey
13. Study includes comorbidity information 0.56 -0.53 0.15 -0.35 0.45 0.00 -0.53 0.00 0.47 -0.45 -0.12 1.00
14. Data from 1980s and 1990s -0.56 0.53 -0.15 0.35 -0.67 0.27 0.53 0.00 -0.47 0.45 0.37 -0.33 1.00
15. Data from 1980s only 0.23 -0.30 0.19 -0.20 0.23 0.02 -0.30 0.10 0.16 -0.23 -0.02 0.49 -0.56 1.00
16. Data from 1990s only 0.41 -0.32 -0.01 -0.21 0.54 -0.32 -0.32 -0.09 0.38 -0.28 -0.40 -0.09 -0.60 -0.33 1.00
Appendix A2. Correlation Matrix of Study Features For Unprofitable Care Studies
Studies comparing NFP and FP 1 2 3 4 5 6
1. Uncompensated care 1.00
2. Unprofitable care -1.00 1.00
3. Explicit model of hospital competition -0.07 0.07 1.00
4. Use panel data estimation methods -0.08 0.08 0.02 1.00
5. California study 0.44 -0.44 0.22 -0.10 1.00
6. Florida study 0.24 -0.24 -0.28 0.30 0.09 1.00
Studies comparing NFP and GOV 1 2 3 4 5 6
1. Uncompensated care 1.00
2. Unprofitable care -1.00 1.00
3. Explicit model of hospital competition 0.00 0.00 1.00
4. Use panel data estimation methods -0.24 0.24 0.29 1.00
5. California study 0.41 -0.41 0.11 -0.10 1.00
6. Florida study
